Literature DB >> 34632951

Deep historical borrowing framework to prospectively and simultaneously synthesize control information in confirmatory clinical trials with multiple endpoints.

Tianyu Zhan1, Yiwang Zhou2, Ziqian Geng1, Yihua Gu1, Jian Kang3, Li Wang1, Xiaohong Huang1, Elizabeth H Slate4.   

Abstract

In current clinical trial development, historical information is receiving more attention as it provides utility beyond sample size calculation. Meta-analytic-predictive (MAP) priors and robust MAP priors have been proposed for prospectively borrowing historical data on a single endpoint. To simultaneously synthesize control information from multiple endpoints in confirmatory clinical trials, we propose to approximate posterior probabilities from a Bayesian hierarchical model and estimate critical values by deep learning to construct pre-specified strategies for hypothesis testing. This feature is important to ensure study integrity by establishing prospective decision functions before the trial conduct. Simulations are performed to show that our method properly controls family-wise error rate and preserves power as compared with a typical practice of choosing constant critical values given a subset of null space. Satisfactory performance under prior-data conflict is also demonstrated. We further illustrate our method using a case study in Immunology.

Entities:  

Keywords:  Bayesian hierarchical model; deep learning; family-wise error rate control; power preservation; prospective algorithm

Mesh:

Year:  2021        PMID: 34632951      PMCID: PMC9257992          DOI: 10.1080/10543406.2021.1975128

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.503


  11 in total

1.  Summarizing historical information on controls in clinical trials.

Authors:  Beat Neuenschwander; Gorana Capkun-Niggli; Michael Branson; David J Spiegelhalter
Journal:  Clin Trials       Date:  2010-02       Impact factor: 2.486

2.  Error bounds for approximations with deep ReLU networks.

Authors:  Dmitry Yarotsky
Journal:  Neural Netw       Date:  2017-07-13

Review 3.  Advances in p-Value Based Multiple Test Procedures.

Authors:  Ajit C Tamhane; Jiangtao Gou
Journal:  J Biopharm Stat       Date:  2017-10-26       Impact factor: 1.051

4.  Modified Goldilocks Design with strict type I error control in confirmatory clinical trials.

Authors:  Tianyu Zhan; Hongtao Zhang; Alan Hartford; Saurabh Mukhopadhyay
Journal:  J Biopharm Stat       Date:  2020-04-16       Impact factor: 1.051

5.  Designed extension of studies based on conditional power.

Authors:  M A Proschan; S A Hunsberger
Journal:  Biometrics       Date:  1995-12       Impact factor: 2.571

6.  Secukinumab in plaque psoriasis--results of two phase 3 trials.

Authors:  Richard G Langley; Boni E Elewski; Mark Lebwohl; Kristian Reich; Christopher E M Griffiths; Kim Papp; Lluís Puig; Hidemi Nakagawa; Lynda Spelman; Bárður Sigurgeirsson; Enrique Rivas; Tsen-Fang Tsai; Norman Wasel; Stephen Tyring; Thomas Salko; Isabelle Hampele; Marianne Notter; Alexander Karpov; Silvia Helou; Charis Papavassilis
Journal:  N Engl J Med       Date:  2014-07-09       Impact factor: 91.245

Review 7.  Use of historical control data for assessing treatment effects in clinical trials.

Authors:  Kert Viele; Scott Berry; Beat Neuenschwander; Billy Amzal; Fang Chen; Nathan Enas; Brian Hobbs; Joseph G Ibrahim; Nelson Kinnersley; Stacy Lindborg; Sandrine Micallef; Satrajit Roychoudhury; Laura Thompson
Journal:  Pharm Stat       Date:  2013-08-05       Impact factor: 1.894

8.  Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE).

Authors:  C Paul; J-P Lacour; L Tedremets; K Kreutzer; S Jazayeri; S Adams; C Guindon; R You; C Papavassilis
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-09-22       Impact factor: 6.166

9.  Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications.

Authors:  Alexandra C Graf; Peter Bauer; Ekkehard Glimm; Franz Koenig
Journal:  Biom J       Date:  2014-04-22       Impact factor: 2.207

10.  Optimizing Graphical Procedures for Multiplicity Control in a Confirmatory Clinical Trial via Deep Learning.

Authors:  Tianyu Zhan; Alan Hartford; Jian Kang; Walter Offen
Journal:  Stat Biopharm Res       Date:  2020-08-24       Impact factor: 1.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.